Urell and Pregnancy

Hopital Foch11 enrolled

Overview

Evaluation of the effect of URELL consumption on the occurrence of recurrent urinary tract infection (Acute cystitis, pyelonephritis and asymptomatic bacteriuria).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Enrollment

Conditions

Urinary Tract Infection (UTI)

Interventions

URELLDIETARY_SUPPLEMENT

PlaceboOTHER

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Pregnant woman in her 4th gestational month or more, having urinary tract infection. Exclusion Criteria: * Pregnant woman with organic or functional urinary tract malformations * Diabetic patients * HIV positive

Locations (1)

Hôpital FOCH

Suresnes, France

Outcomes

Primary Outcomes

Recurrence of Urinary tract infections

Time frame: From the 4th gestational month till the end of pregnancy (about the 40th gestational week)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.